Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

AMYPAD holds its General Assembly Meeting

14th October 202110th October 2021
AMYPAD logo

On 8 and 9 October, the “Amyloid imaging to Prevent Alzheimer’s disease” (AMYPAD) consortium held

3-dimensional representation of European data availability landscape for Alzheimer’s disease research

6th October 20216th October 2021
This Cube offers a dynamic overview of the 'landscape' of data availability in Europe for Alzheimer's disease (AD) research

The Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access

Davos Alzheimer’s Collaborative intends to award up to $2M to 3-5 innovators in Spring of 2022

5th October 2021
DAC RFP social card 3

The Davos Alzheimer’s Collaborative (DAC) was initiated by The World Economic Forum (WEF) and The

Neuronet co-hosts European Parliament Workshop on The Innovative Health Initiative: Building on success of the Innovative Medicines Initiative

1st October 20211st October 2021
EP workshop

About the event On 28 September, Alzheimer Europe and Neuronet co-hosted an online European Parliament

Open Position as Senior Business Strategy Developer for the European Platform for Neurodegenerative Disorders

10th January 202230th September 2021

About the job The Senior Business Strategy Developer will be responsible for the development of

Open Position as Postdoctoral fellow in the field of clinical and translational medicine informatics in Luxembourg

29th September 202129th September 2021
LCSB-logo

The University of Luxembourg is an international research university with a distinctly multilingual and interdisciplinary

Neuronet says farewell to Diana O’Rourke and welcomes Fatima Salih to the team

26th September 2021
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

On 26 September 2021, Diana O’Rourke left her position as Senior Analyst at the National

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

23rd September 2021
PD-MITOQUANT logo Newsletter Mitochondrial dysfunction Parkinson

The latest Innovative Medicines Initiative (IMI) funded PD-MitoQUANT publication shows that Microglia form F-actin dependent

The open source platform for remote assessment using wearable devices and mobile applications

22nd September 2021
RADAR Base

RADAR-base is an open source platform that aims to help researchers to leverage data from wearables and mobile technologies.

Improving the identification, access and assessment, and (re)use of health data within the European Union

20th September 2021
EMIF European Medical Information Framework

During its project lifetime, the European Medical Information Framework (EMIF) has developed and made the

Post navigation
Older posts
Newer posts
← Previous Page1 … Page9 Page10 Page11 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT